Data from the Swedish Stroke Registry (Riksstroke) and the Swedish Macula Register (SMR) were cross‐linked to identify nAMD patients who developed stroke/TIA within 90 days after intravitreal anti‐VEGF injection. The gene discussed is VEGFA; the disease is transient ischemic attack.